DILH
IMPV

Dai-ichi Life Holdings’s Imperva, Inc. IMPV Stock Holding History

Dai-ichi Life Holdings’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-31,538
Closed -$1.69M – 526
2016
Q3 		$1.69M Buy
+31,538
New +$1.46M 0.05% 325

Other funds holding IMPV

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LM
Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dai-ichi Life Holdings's IMPV Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Imperva, Inc. (IMPV) in Q4 2016, closing a stake of 31,538 shares — an estimated $1.69M sold.

Dai-ichi Life Holdings first reported a position in IMPV in Q3 2016 and held it in 1 quarter. The position peaked at $1.69M in Q3 2016. 172 funds tracked by Wall St. Rank hold IMPV as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Imperva, Inc. position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 31,538 Imperva, Inc. shares in Q4 2016, an estimated $1.69M.
  • Dai-ichi Life Holdings first reported a position in Imperva, Inc. in Q3 2016 and held it in 1 quarter.
  • Dai-ichi Life Holdings's Imperva, Inc. position peaked at $1.69M in Q3 2016.
  • 172 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.